Follow
CAR-T cell therapy
Chimeric antigen receptor (CAR) T cell therapy is a form of T cell engineering where T cells are obtained from a patient and engineered in a laboratory to better kill the patient's cancer cells. Specifically, CAR T cells are modified to express a receptor on their surface that recognizes the specific antigen present on the patient's cancer cells.
What's Popular in CAR-T cell therapy
-
MAR 06, 2024Health & Medicine
Gone are the days when therapies for medical conditions were based solely on statistical data of the broad population, l ...Sponsored By: ESSERT RoboticsMAR 04, 2024Cell & Molecular Biology
With astonishing advances in molecular biology, cell and gene therapies represent a new class of pharmaceuticals availab ...Sponsored By: Single Use SupportFEB 29, 2024Immunology
Jennifer Doudna and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in g ...Written By: Brian G. MorrealeFEB 22, 2024Immunology
The US Food and Drug Administration (FDA) recently approved a tumor-infiltrating lymphocyte (TIL) therapy referred to as ...Written By: Brian G. MorrealeFEB 15, 2024Immunology
There are various ways to treat cancer. The gold standard has been chemotherapy for over 50-years. However, treatment wi ...Written By: Brian G. Morreale
MAR 06, 2024
Health & Medicine
Gone are the days when therapies for medical conditions were based solely on statistical data of the broad population, l
...
Sponsored By:
ESSERT Robotics
MAR 04, 2024
Cell & Molecular Biology
With astonishing advances in molecular biology, cell and gene therapies represent a new class of pharmaceuticals availab
...
Sponsored By:
Single Use Support
FEB 29, 2024
Immunology
Jennifer Doudna and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in g
...
Written By:
Brian G. Morreale
FEB 22, 2024
Immunology
The US Food and Drug Administration (FDA) recently approved a tumor-infiltrating lymphocyte (TIL) therapy referred to as
...
Written By:
Brian G. Morreale
FEB 15, 2024
Immunology
There are various ways to treat cancer. The gold standard has been chemotherapy for over 50-years. However, treatment wi
...
Written By:
Brian G. Morreale
FEB 08, 2024
Immunology
Summary: Engineered immune cells, known as T cells, were found to eliminate anti-immune cells connected to age-associate
...
Written By:
Brian G. Morreale
DEC 14, 2023
Immunology
A novel immune cell therapy known as Chimeric Antigen Receptor (CAR) T cell therapy has recently demonstrated efficacy i
...
Written By:
Brian G. Morreale
NOV 30, 2023
Immunology
Engineered immune cells have been the topic of investigation for the last few decades. Just 11 years ago a child was tre
...
Written By:
Brian G. Morreale
NOV 29, 2023
Cancer
The CAR-T Revolution: Developing T Cells into Cancer Assassins Cancer has long been a formidable foe, but recent
...
-
On DemandC.E. CREDITS
The study of a single cell, the fundamental unit of our complex bodies, has become an important field in cellular biology, and researchers are using single-cell analysis to shed new light on...
NOV 07, 2023 | 10:00 AM
In the last 5 years, the US Food and Drug Administration has approved 4 anti-CD19 chimeric antigen receptor T cell (CART19) products for relapsed/refractory B cell lymphomas and leukemia. Ho...
SEP 28, 2023 | 7:00 AM
Webinars will be available for unlimited on-demand viewing after live event. Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the AS...
SEP 14, 2023 | 8:00 AM
Flow cytometry plays a crucial role in the rapidly growing field of cell therapy, this method is used to identify different types of cells throughout the manufacturing process, from initial...
SEP 06, 2023 | 8:00 AM
The expansion and persistence of CAR T cells within patients is the key to a successful treatment. Therefore, monitoring of CD19 CAR T cells following infusion is of utmost interest. The CAR...
Speaker:
Dr. Annika Graband
, Dr. Sabine Hünecke
, Dr. Melanie Bremm
Sponsored By: Miltenyi Biotec
On Demand
C.E. CREDITS
The study of a single cell, the fundamental unit of our complex bodies, has become an important field in cellular biology, and researchers are using single-cell analysis to shed new light on...
NOV 07, 2023 | 10:00 AM
In the last 5 years, the US Food and Drug Administration has approved 4 anti-CD19 chimeric antigen receptor T cell (CART19) products for relapsed/refractory B cell lymphomas and leukemia. Ho...
SEP 28, 2023 | 7:00 AM
Webinars will be available for unlimited on-demand viewing after live event. Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the AS...
SEP 14, 2023 | 8:00 AM
Flow cytometry plays a crucial role in the rapidly growing field of cell therapy, this method is used to identify different types of cells throughout the manufacturing process, from initial...
SEP 06, 2023 | 8:00 AM
The expansion and persistence of CAR T cells within patients is the key to a successful treatment. Therefore, monitoring of CD19 CAR T cells following infusion is of utmost interest. The CAR...
Speaker:
Dr. Annika Graband
, Dr. Sabine Hünecke
, Dr. Melanie Bremm
Sponsored By: Miltenyi Biotec
AUG 23, 2023 | 8:00 AM
Do you want to bring your CAR NK cell and Treg cell research into clinical applications? Watch this webinar and explore Miltenyi Biotec’s solutions to advance CAR NK cell and Treg-base...
Speaker:
Dr. Julia Hengst
, Dr. Martha Elia Luevano Salinas
, Dr. Alina Steinbach
Sponsored By: Miltenyi Biotec
AUG 16, 2023 | 8:00 AM
Watch this webinar and explore Miltenyi Biotec’s solutions to advance CAR T-cell therapies – from basic research to process development and clinical manufacturing. Discover the p...
Speaker:
Dr. Annika Graband
, Dr. Melanie Rietenbach
, Dr. Saskia Rösch
Sponsored By: Miltenyi Biotec
JUL 26, 2023 | 3:10 PM
Cell-based immunotherapy has become the new-generation cancer medicine, and “off-the-shelf” cell products that can be manufactured at large scale and distributed readily to treat...
JUL 26, 2023 | 11:20 AM
Chimeric antigen receptor (CAR)-reprogrammed immune cells offer exciting therapeutic potential for addressing oncology, autoimmune diseases, transplant medicine, and infections. However, cur...
Speaker:
Dr. Dimitrios L. Wagner
Presented at: GenScript 3rd Annual Gene and Cell Engineering Summit
-
Labroots and the Cell & Gene Therapy planning committee are pleased to announce the inaugural Cell & Gene Therapy Virtual Event Series, taking place on October 15th, 2025. The Cell &...
Labroots and the Cell & Gene Therapy planning committee are pleased to announce Cell & Gene Therapy Virtual Event Series, taking place on October 14th, 2026. The Cell & Gene Ther...OCT 16, 2024 | 6:00 AM PDTC.E. CREDITS
The inaugural Labroots Cell & Gene Therapy Virtual Event Series will take place on October 16th, 2024....JUL 26, 2023 | 8:00 AM PDT
GenScript is delighted to announce its 3rd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, le...JAN 23 - 26, 2023
At Bionano, we're on a mission to transform the way the world sees the genome. Our genome mapping systems provide sensitive, unbiased, genome-wide structural variant detection, and our genomi...
Labroots and the Cell & Gene Therapy planning committee are pleased to announce the inaugural Cell & Gene Therapy Virtual Event Series, taking place on October 15th, 2025. The Cell &...
Labroots and the Cell & Gene Therapy planning committee are pleased to announce Cell & Gene Therapy Virtual Event Series, taking place on October 14th, 2026. The Cell & Gene Ther...
OCT 16, 2024
| 6:00 AM PDT
C.E. CREDITS
The inaugural Labroots Cell & Gene Therapy Virtual Event Series will take place on October 16th, 2024....
JUL 26, 2023
| 8:00 AM PDT
GenScript is delighted to announce its 3rd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, le...
JAN 23 - 26, 2023
At Bionano, we're on a mission to transform the way the world sees the genome. Our genome mapping systems provide sensitive, unbiased, genome-wide structural variant detection, and our genomi...
NOV 02, 2022
| 5:30 AM PDT
Labroots invites you to the 5th Annual Event in the CRISPR Virtual Event Series! This event will continue the conversation on the abilities of CRISPR-based editing, and much more....
OCT 19, 2022
| 5:30 AM PDT
Labroots announces the 2022 Coronavirus Virtual Event Series. A novel coronavirus emerged in China in 2019; it has since been dubbed COVID-19....
OCT 04, 2022
| 5:30 AM PDT
Labroots to host the 10th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series! This two day event will take place on October 4-6, 2022....
JUL 28, 2022
| 8:00 AM PDT
GenScript is delighted to announce its 2nd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, lev...